The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis of Existing Guidelines and Randomized, Controlled, Clinical Trials for Development of [Guideline of Clinical Trial with Herbal Medicinal Product for gastric cancer]

위암 한약제제 임상시험 가이드라인 개발을 위한 한약제제 무작위배정 대조군 임상시험 고찰

  • Han, Gajin (Soram Korean Medicine Hospital) ;
  • Seong, Sin (Soram Korean Medicine Hospital) ;
  • Kim, Sungsu (Soram Korean Medicine Hospital) ;
  • Kim, Jinsung (Department of Gastroenterology, College of Korean Medicine, Kyung Hee University) ;
  • Park, Jae-Woo (Department of Gastroenterology, College of Korean Medicine, Kyung Hee University)
  • 한가진 (소람한방병원) ;
  • 성신 (소람한방병원) ;
  • 김성수 (소람한방병원) ;
  • 김진성 (경희대학교 한의과대학 비계내과학 교실) ;
  • 박재우 (경희대학교 한의과대학 비계내과학 교실)
  • Received : 2017.08.29
  • Accepted : 2017.09.12
  • Published : 2017.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study aimed to learn what should be considered in [Guideline of Clinical Trial with Herbal Medicinal Product for Gastric Cancer)] by analyzing the existing guidelines and clinical trials. Methods: The development committee searched guidelines for herbal medicinal product or gastric cancer developed already. Then, clinical trials for gastric cancer using herbal medicine were searched. The searched trials were analyzed in terms of inclusion and exclusion of participants, intervention, comparator, outcomes and trial design. Then, we compared the results of analysis with the regulations and guidelines of Ministry of Food and Drug Safety to suggest the issue that we will have to consider when making the [Guideline of Clinical Trial with Herbal Medicinal Product for Gastric Cancer]. Results: As a result, few guidelines for anti-tumor agent and clinical trial with herbal medicinal product were searched in the national institution homepage. In addition, 10 articles were searched by using the combination following search term; 'stomach neoplasm', 'herbal medicine', 'Medicine, Korean traditional', 'Medicine, Chinese Traditional', 'TCM', 'TKM', 'trial'. Most trials included gastric cancer participants with medical history of operation. The type of intervention was various such as decoction, granules, and fluid of intravenous injection. Comparators were diverse such as placebo, conventional treatment including chemotherapy and nutritional supplement. The most frequently used outcome for efficacy was quality of life. Besides, the symptom score, tumor response, and survival rate were used. Safety was investigated by recording adverse events. Conclusion: We found out some issue by reviewing the existing guidelines and comparing it with clinical trials for gastric cancer and herbal medicinal products. These results will be utilized for developing [Guideline of Clinical Trial with Herbal Medicinal Product for Gastric Cancer].

Keywords

References

  1. Ministry of Health and Welfare. National Cancer Registration Statistics Reference 2014. 2016.12.20.
  2. National Cancer Information Center. Gastric Cancer 2014. Avaliable at: URL:http://www.cancer.go.kr/mbs/cancer/index.jsp.
  3. Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ, et al. Synopsis on Clinical Practice Guideline of Gastric Cancer in Korea: An Evidence-Based Approach. Korean J Gastroenterol. 2014;63(2):66-81. https://doi.org/10.4166/kjg.2014.63.2.66
  4. Cheung DY, Kim JK. Perspectives of the Stomach Cancer Treatment: The Introduction of Molecular Targeted Therapy and the Hope for Cure. Korean J Gastroenterol. 2013;61(3):117-27. https://doi.org/10.4166/kjg.2013.61.3.117
  5. SB Jang, et al. A Study on Complementary Alternative Therapy Used by Cancer Patients in Korea. Korean J Adult Nurs. 2006;18(1):92-101.
  6. Lee Ei, Shin YC, Lee JH, Kim SD, Kim HJ, Cho MS. Use of Complementary and Alternative Medicine in Cancer Patients at 7 General Hospitals in Seoul. J Korea Public Health Assoc. 2002;28(3): 225-38.
  7. Ha TH, Seong S, Lee DH, Kim SS. Improved Case of Recurred and Metastatic Ascending Colon Cancer by Combination of Oriental Medical Therapy and FOLFIRI Chemotherapy. Korean J Oriental Physiology & Pathology. 2013;26(1):148-51.
  8. Cheon SH, Kim KS, Kim S, Jung HS, Choi WC, Eo WK. Efficacy and Safety of Rhus verniciflua Stokes Extracts in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer. Forsch Komplementmed. 2011;18(2):77-83.
  9. Kim BJ, Moon G. An Outlook of the Oriental and Western Medical Diagnosis and Treatment on Gastric Cancer. KOMS. 1996;17(2):100-16.
  10. Hwang CY. Bibliographic Study on the Therapy of Gastric Cancer by Intergrated Oriental and Western Medicine. The Journal of Wonkwang Oriental Medicine. 1997;7(1):10-8.
  11. Jung JH, Seo JC, Kwak MA, Sohn KC. Literature Review on Traditional Chinese Medicine Treatment of Gastric Cancer. J Int Korean Med. 2014;35(3):332-42.
  12. Sim BS, Choi SH. A Literatural Study on Pattern Identification Type of Stomach Cancer. J of Oriental Medical Pathology. 1993;8:295-303.
  13. Nationwide Medical College of Oriental Gastroenterology Medicine. Oriental Gastroenterology. Seoul: Koonja Publisher Co. 2008:126-36.
  14. Korea Health Industry Development Institute. Clinical trial status and prospect of domestic drug. Seoul: Korea Health Industry Development Institute. 2006:7-14.
  15. Kim HR, Jeong HR, Baek DG, Won JH, Moon G. Clinical Practice Guidelines of Korean Medicine for Gastric Cancer. Journal of Korean traditional oncology. 2014;19(1):1-24. https://doi.org/10.15432/JKTO.2014.19.1.1
  16. Kim HR, Yoo HS, Beak DG, Park IH, Jang CY, Kim HY. Clinical Practice Guidelines in Korean Medicine for Gastric Cancer. Korean J Orient Int Med. 2016;37(1);25-46.
  17. Kim SH, Namgung MA, Chang YS, Jeong SK, Kim JS, Yoon SW, et al. Study on Development of Assessment Guideline and Endpoints for Clinical Trial with Antitumor Natural Products. Korean J Oriental Physiology & Pathology. 2006;20(6):1678-1727.
  18. National Institute of Food and Drug Safety Evaluation. Guidelines for clinical trial of anticancer drugs. 2015.12
  19. National Institute of Food and Drug Safety Evaluation. Guidelines for non-clinical trial of anticancer drugs. 2015.12
  20. Ministry of Food and Drug Safety. Guideline for evaluation of clinical trial of anticancer drugs.
  21. National Institute of Food and Drug Safety Evaluation. Guidelines for Exemption of Anticancer Drug Data in Bridging Study. 2015.07.
  22. Ministry of Food and Drug Safety. General considerations in clinical trials of herbal medicine preparations. Seoul:Ministry of Food and Drug Safety. 2007.
  23. Korean Institution of Oriental Medicine. A study on the clinical trial guidelines of herbal medicinal drug. Seoul:Ministry of Food and Drug Safety. 2004.
  24. Industry-Academia Collaboration Foundation, Kyung Hee University. Research on outcome indicators for clinical trials of herbal medicinal products. Seoul:Ministry of Food and Drug Safety. 2006.
  25. Yoshikawa K, Shimada M, Wakabayashi G, Ishida K, Kaiho T, Kitagawa Y,et al. Effect of Daikenchuto, a Traditional Japanese Herbal Medicine, after Total Gastrectomy for Gastric Cancer: A Multicenter, Randomized, Double -Blind, Placebo-Controlled, Phase II Trial. J Am Coll Surg. 2015;221(2):571-8. https://doi.org/10.1016/j.jamcollsurg.2015.03.004
  26. Takahashi T, Endo S, Nakajima K, Souma Y, Nishida T. Effect of rikkunshito, a chinese herbal medicine, on stasis in patients after pylorus-preserving gastrectomy. World J Surg. 2009;33(2):296-302. https://doi.org/10.1007/s00268-008-9854-8
  27. Akamaru Y, Takahashi T, Nishida T, Omori T, Nishikawa K, Mikata S, et al. Effects of daikenchuto, a Japanese herb, on intestinal motility after total gastrectomy: a prospective randomized trial. J Gastrointest Surg. 2015;19(3):467-72. https://doi.org/10.1007/s11605-014-2730-y
  28. Wang HZ, Wang HB, Gao H. Clinical observation on treatment of 34 advanced gastric carcinoma patients by chemotherapy of DCF regimen combined with Fuzheng Hewei Decoction. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007;27(10):927-9.
  29. Yin SH, Du YQ, Liu B. Clinical study on acupuncture combined with medication in restoration of gastrointestinal functions for postoperative patients with gastric cancer. Zhongguo Zhen Jiu. 2009;29(6):459-62.
  30. Wang H, Guo LJ, Wu B. Effect of rhubarb combined with enteral nutrition on C-reactive protein and interleukin-6 in peripheral blood of patients with gastric cancer during perioperative period. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28(2):101-4.
  31. Cai J, Wang H, Zhou S, Wu B, Song HR, Xuan ZR. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao. 2008;6(1):37-40. https://doi.org/10.3736/jcim20080108
  32. Wang Y, Wang YT, Lin YH, Zou ZD. Effects of Xuesaitong injection on coagulation function of gastric cancer patients undergoing laparoscopic surgery: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao. 2009;7(6):514-7. https://doi.org/10.3736/jcim20090604
  33. Huang CX, Chen LZ, Zhao JG. Influence of chemotherapy with FOLFOX protocol on sex hormones of male patients and the protective effect of herbal medicines for reinforcing Shen and supplementing qi on it. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28(11):986-9.
  34. Sun DZ, Jiao JP, Zhang X, Xu JY, Ye M, Xiu LJ, et al. Therapeutic effect of Jinlongshe Granule on quality of life of stage IV gastric cancer patients using EORTC QLQ-C30: A double-blind placebo-controlled clinical trial. Chin J Integr Med. 2015;21(8):579-86. https://doi.org/10.1007/s11655-014-1950-z
  35. Cheon CH, Park SJ, Jang BH, Shin YC, Ko SG. The Analysis of usage of Symptom Differentiation in Clinical Trials in Korean Medicine for Cancer Patients. spkom. 2015:19(1):61-70.
  36. Lyseng-Williamson KA, Fenton C. Docetaxel: a review of its use in metastatic breast cancer. Drugs. 2005;65(17):2513-31. https://doi.org/10.2165/00003495-200565170-00007
  37. Jeong TY, Lee YW, Cho JG, Yoo HS. Analysis of Clinical Characteristics for 899 Cancer Patients Treated at an Oriental Hospital. Korean J Orient Int Med. 2010;31(1):102-12.
  38. Lin H. Guidelines of Diagnosis and Therapy in Oncology with Traditional Chinese Medicine. Beijing: Renminweisheng Press; 2014, p. 306-38.
  39. Lee JI, Shim KY, Kim HY, Choi SY, Bang DG, Cho KS. Clinical Study of the Efficacy of Combined Western-Oriental Medicine for Gastric Cancer and Hepatocellular Carcinoma. J of Kor Traditional Oncology. 2001;7(1):117-129.
  40. Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ, et al. Synopsis on Clinical Practice Guideline of Gastric Cancer in Korea: An Evidence-Based Approach, Korean J Gastroenterol. 2014;63(2):66-81. https://doi.org/10.4166/kjg.2014.63.2.66
  41. Kong KH, Ha J, Baek TH. One Case on Diagnosis and Treatment Based on an Overall Analysis of Signs and Symtoms of Stomach Cancer stage IV. Korean J Orient Int Med. 2000;21(5):897-902.
  42. Sim BS, Choi SH. A Literatural Study on Pattern Identification Type of Stomach Cancer. J of Oriental Medical Pathology. 1993;8:295-303.
  43. Hwang SY, Ahn SH, Keum KS. Proposal on Supplementation to Oriental Medical Policy for the Revitalization of Oriental Medical Therapy for Stomach Cancer. Korean J Oriental Physiology & Pathology. 2009;23(3):528-33.
  44. Nationwide Medical College of Oriental Gastroenterology Medicine. Oriental Gastroenterology. Seoul:Koonja Publisher Co. 2008:126-36.
  45. Lee NH, Cho JH, Son CG, Yoo HS, Lee YW, Yoon DH, et al. Analysis of Studies on Quality of Life according to Cancer Types and Symptoms. Korean J Orient Int Med. 2006:27(3):555-60.
  46. Lee EH, Park HB, Kim MW, Kang SH, Lee HJ, Lee WH, et al. Analyses of the Studies on Cancer-Related Quality of Life Published in Korea. Radiat Oncol J. 2002.29(4):359-66.

Cited by

  1. 결장직장암 한약제제 임상시험 가이드라인 개발을 위한 한약제제 대조군 임상시험 고찰 vol.40, pp.1, 2017, https://doi.org/10.13048/jkm.19011
  2. 기능성 위장관 질환의 한의학적 치료 연구전략 수립을 위한 연구 동향 분석 vol.29, pp.1, 2021, https://doi.org/10.14374/hfs.2021.29.1.57